Cargando…
Molecular Oncology of Bladder Cancer from Inception to Modern Perspective
SIMPLE SUMMARY: Bladder cancer (BC) is a common cancer that causes high morbidity and mortality among affected patients. As a carcinogen-driven cancer, molecular oncology of BC has contributed to several fundamental concepts in cancer biology. Molecular insights into the divergent pathways for low-...
Autores principales: | Lokeshwar, Soum D., Lopez, Maite, Sarcan, Semih, Aguilar, Karina, Morera, Daley S., Shaheen, Devin M., Lokeshwar, Bal L., Lokeshwar, Vinata B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179261/ https://www.ncbi.nlm.nih.gov/pubmed/35681556 http://dx.doi.org/10.3390/cancers14112578 |
Ejemplares similares
-
Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma
por: Wang, Jiaojiao, et al.
Publicado: (2022) -
Wee1-Hsp90 inhibitor combination treatment: Molecular therapy with potentially broad applicability
por: Lokeshwar, Vinata B.
Publicado: (2012) -
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets
por: Morera, Daley S, et al.
Publicado: (2017) -
Molecular targeting of renal cell carcinoma by an oral combination
por: Jordan, Andre R., et al.
Publicado: (2020) -
Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer
por: Jordan, Andre R., et al.
Publicado: (2016)